Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...

Founded in 2012, 10x Genomics (NASDAQ:TXG) develops single-cell and spatial genomics solutions, enabling researchers to ...

Fintel reports that on February 13, 2025, Leerink Partners downgraded their outlook for 10x Genomics (NasdaqGS:TXG) from ...

Sequencing will be performed on the UG 100 ... chan-zuckerberg-initiative-launches-billion-cells-project-with-10x-genomics-and-ultima-genomics-to-advance-ai-in-biology-302369647.html Smart ...

Coupled with the invalidation of 10x Genomics’ 10,155,981 patent last ... differentiated solution that makes single cell sequencing more scalable without the need for expensive microfluidics.

Decision Marks a Significant Legal Victory for Parse Biosciences, Reinforcing Commitment to Innovation and Fair Competition ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

10x Genomics, Inc. (NASDAQ:TXG), a biotechnology company based in California, develops gene sequencing technology for scientific research. The company sells a variety of items, including reagent ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular ...

Today, the Chan Zuckerberg Initiative (CZI) launched the Billion Cells Project, an effort to generate an unprecedented one billion cell dataset to fuel rapid progress in AI model development in ...